An observational study in Atrial Cardiopathy, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 17 Years to 90 Years. Per ClinicalTrials.gov, last updated 2022-11-30.
Sponsored by Assiut University · Observational
Marker of atrial cardiopathay as apredictor value of ischemic stroke
detection of the presence of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with a one-year follow-up for any cardioembolic events (stroke /TIA).
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
This study's planned enrollment of 30 is below the median of 294 across 1,241 observational studies indexed under Heart Diseases.
Browse Heart Diseases studies →Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Valvular AF, moderate to severe mitral/ tricuspid/ aortic stenosis or regurgitation.
Decompensation stage of organ failure
A 24-h ambulatory Holter Echocardiography Speckle tracking echocardiography (STE)
Detection of any underlying arrythmia after holter monitoring for twenty four hours
Detection of any underlying arrythmia after holter monitoring for twenty four hours
Time frame: Detection of any underlying arrythmia after holter monitoring for twenty four hours
Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).
Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).
Time frame: Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University